SCHEMBL8936703

SCHEMBL8936703

Cn1nnc2ccc(C(Cl)c3ccc(Cl)cc3CO[Si](C)(C)C(C)(C)C)cc21

nearest known ligand 0.41

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 5/20 0.41
CYP11B1 P15538 1/20 0.41
SLC6A4 P31645 1/20 0.38
KEAP1 Q14145 3/20 0.36
TSHR P16473 2/20 0.31
SMN1; SMN2 Q16637 2/20 0.31
CASP3 P42574 1/20 0.31
KMT2A Q03164 1/20 0.31
SENP8 Q96LD8 1/20 0.31
SENP7 Q9BQF6 1/20 0.31
SENP6 Q9GZR1 1/20 0.31
FAAH O00519 1/20 0.31
KMO O15229 1/20 0.31
CRHBP P24387 1/20 0.30
RECQL P46063 1/20 0.30
CRHR2 Q13324 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8936707 0.89 CYP19A1 (0.40) CYP19A1CYP11B1SLC6A4KEAP1TSHR
SCHEMBL8936708 0.79 CYP19A1 (0.40) CYP19A1CYP11B1SLC6A4KEAP1TSHR
SCHEMBL8936776 0.79 SLC6A4 (0.46) CYP19A1CYP11B1SLC6A4KEAP1TSHR
SCHEMBL8884360 0.73 CYP19A1 (0.60) CYP19A1CYP11B1SLC6A4KEAP1KMT2A
SCHEMBL9523659 0.70 CYP19A1 (0.50) CYP19A1CYP11B1SLC6A4KEAP1KMT2A
SCHEMBL30235581 0.70 KEAP1 (0.43) KEAP1
SCHEMBL14476937 0.67 KEAP1 (0.53) CYP19A1CYP11B1SLC6A4KEAP1KMT2A
SCHEMBL18322394 0.67 NFE2L2 (0.38) KEAP1
SCHEMBL17494783 0.66 BACE1 (0.33) KMT2A
SCHEMBL17494744 0.66 TDP1 (0.41) SMN1; SMN2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5587392-A THERAPY FOR ESTROGEN DEPENDENT DISEASES MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 1996-12-24 US disclosed
EP-0684235-A1 Novel azolyl methyl phenyl derivatives having aromatase inhibitory activity MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 1995-11-29 EP disclosed